<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"
  dtd-version="1.3" xml:lang="en" article-type="research-article">
  <?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?>
  <?DTDIdentifier.IdentifierType public?>
  <?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
  <?SourceDTD.Version 1.2?>
  <?ConverterInfo.XSLTName jats2jats3.xsl?>
  <?ConverterInfo.Version 1?>
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="iso-abbrev">Arch Pharm Pract</journal-id>
      <journal-id journal-id-type="publisher-id">archivepp.com</journal-id>
      <journal-id journal-id-type="publisher-id">Arch Pharm Pract</journal-id>
      <journal-title-group>
        <journal-title>Archives of Pharmacy Practice</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2320-5210</issn>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">archivepp.com-1182</article-id>
      <article-id pub-id-type="doi">10.51847/InxP3DB3C6</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original research</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Post-Intensive Care Syndrome Scale: Turkish Validity and Reliability Study</article-title>
      </title-group>
                    <contrib-group>
                      <contrib contrib-type="author">
              <name>
                <surname>Güven</surname>
                <given-names>Suzan</given-names>
              </name>
                              <xref rid="aff1" ref-type="aff">1</xref>
                                                            <xref rid="cor1" ref-type="corresp" />
                          </contrib>
                      <contrib contrib-type="author">
              <name>
                <surname>Çınar</surname>
                <given-names>Fadime</given-names>
              </name>
                              <xref rid="aff2" ref-type="aff">2</xref>
                                        </contrib>
                      <contrib contrib-type="author">
              <name>
                <surname>Aslan</surname>
                <given-names>Fatma Eti</given-names>
              </name>
                              <xref rid="aff3" ref-type="aff">3</xref>
                                        </contrib>
                  </contrib-group>
                  <aff id="aff1">
            <label>1</label>Faculty of Health Sciences, Van Yuzuncu Yıl University, Van, Turkey.
          </aff>
                  <aff id="aff2">
            <label>2</label>Faculty of Health Sciences, Nisantasi University, Istanbul, Turkey.
          </aff>
                  <aff id="aff3">
            <label>3</label>Faculty of Health Sciences, Bahçeşehir University, Istanbul, Turkey.
          </aff>
                          <author-notes>
            <corresp id="cor1">
              <bold>Address for correspondence:</bold> Prof. Wael Abu Dayyih, Department of
              Pharmaceutical Chemistry, Faculty of Pharmacy, Mutah University, Al-Karak 61710, Jordan.
                              E-mail: <email xlink:href="suzanguven@yyu.edu.tr">suzanguven@yyu.edu.tr</email>
                          </corresp>
          </author-notes>
                    <pub-date pub-type="epub">
        <day>26</day>
        <month>03</month>
        <year>2024</year>
      </pub-date>
      <volume>15</volume>
      <issue>2</issue>
      <fpage>20</fpage>
      <lpage>25</lpage>
      <permissions>
        <copyright-statement>
          Copyright: &#x000a9; 2026 Archives of Pharmacy Practice
        </copyright-statement>
        <copyright-year>2026</copyright-year>
        <license>
          <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/"
            specific-use="textmining" content-type="ccbyncsalicense">
            https://creativecommons.org/licenses/by-nc-sa/4.0/</ali:license_ref>
          <license-p>This is an open access journal, and articles are distributed under the terms of
            the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows
            others to remix, tweak, and build upon the work non-commercially, as long as appropriate
            credit is given and the new creations are licensed under the identical terms.</license-p>
        </license>
      </permissions>
      <abstract>
        <title>A<sc>BSTRACT</sc></title>
        <p>This study aimed to analyze the Turkish validity and reliability of a scale to be used for the assessment of post-intensive care syndrome in patients surviving in the intensive care unit. This is a methodological study in which the Turkish version of the &quot;Post-Intensive Care Syndrome Scale&quot; developed by Jeong and Kang (2019) was performed. The population of the study consists of 350 people. The sample consisted of 225 patients due to voluntary participation, unavailability, and death. The researchers collected data by applying the Post-Intensive Care Syndrome Scale. The data in the scale were measured as a number, percentage, standard deviation, minimum, maximum, and mean. Exploratory Factor Analysis (EFA) and Confirmatory Factor Analysis (CFA) were applied for language and content validity and construct validity of the scale. There was a high level of agreement between the expert opinions regarding the items of the scale in terms of content validity of the &quot;Post Intensive Care Syndrome Scale&quot; (CSR=0.96). Exploratory factor analysis revealed that the scale has a three-factor structure, 17 items explained 69.64% of the total variance, and factor loadings ranged between 0.48-0.86. According to confirmatory factor analysis, Chi-square/sd=2.719 non-normed fit index=0.89 and comparative fit index=0.93. Cronbach&amp;#39;s alpha reliability coefficient was 0.93. The study results showed the Turkish version of the Post-Intensive Care Syndrome. Scale meets the Turkish version criteria at an acceptable level and can be used in scientific research.</p>
      </abstract>
      <kwd-group>
                <kwd>Intensive care</kwd>
                <kwd>Post-intensive care syndrome</kwd>
                <kwd>Scale</kwd>
                <kwd>Validity</kwd>
                <kwd>Reliability</kwd>
              </kwd-group>
    </article-meta>
  </front>
</article>